3/A

FORM 3/A SUBMISSION

Company: Phio Pharmaceuticals Corp.
Filed: April 14, 2017
Period of Report: April 12, 2017
Accession Number: 0001209191-17-026989

View Document ↗ View on SEC.gov ↗